Difficult Choices in Stage I Uterine Leiomyosarcoma— it's okay to “stand there” Editorial Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • CA-125 Antigen
  • Carcinoma
  • Ovarian Neoplasms

publication date

  • October 2017

Research

keywords

  • Editorial

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2017.09.004

PubMed ID

  • 28923359

Additional Document Info

start page

  • 1

end page

  • 2

volume

  • 147

number

  • 1